General Information of the Cell Line
Cell Line ID
CL000756
Cell Line Name
MCF/MX
Synonyms
MCF-7/MX
MCF-7/mtxR
Category
Cancer cell line
Organism
Homo sapiens (Human)
Tissue Information
Pleural effusion
Disease
Invasive breast carcinoma of no special type (NCIt: C4194)
Map of Molecular Bioactivity Related to the Cell Line
Map of Molecular Bioactivity Related to the Cell Line

Cell Line
Protein
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Cell Line
Protein ID: PT02718, ATP-binding cassette sub-family G member 2
Compound ID Compound Name Compound Formula
CP0391014
2-[4-(7-methyl-2-pyridin-3-yl-5,6,7,8-tetrahydro-[1]benzothiolo[2,3-d]pyrimidin-4-yl)piperazin-1-yl]-2-phenylacetamide
   Show/Hide
C28H30N6OS
 3
1
EC50 = 2730 nM
   TI
   LI
   LO
   TS
2
GI50 = 22400 nM
   TI
   LI
   LO
   TS
3
GI50 = 75400 nM
   TI
   LI
   LO
   TS
CP0141589
3-((3S,6S)-6-Isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydro-pyrazino[1',2':1,6]pyrido[3,4-b]indol-3-yl)-propionic acid tert-butyl ester
   Show/Hide
C26H35N3O5
 3
1
IC50 = 230 nM
   TI
   LI
   LO
   TS
2
IC50 = 330 nM
   TI
   LI
   LO
   TS
3
IC50 = 390 nM
   TI
   LI
   LO
   TS
CP0254388
5-Methoxy-9-oxo-9,10-dihydro-acridine-4-carboxylic acid {4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-ethyl]-phenyl}-amide
   Show/Hide
C34H33N3O5
 1
1
IC50 = 400 nM
   TI
   LI
   LO
   TS
CP0316526
N-[4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]-2-[(4-nitrophenyl)carbamoylamino]benzamide
   Show/Hide
C33H33N5O6
 1
1
IC50 = 540 nM
   TI
   LI
   LO
   TS
CP0116921
1N-{4-[2-(6,7-dimethoxy-1,2,3,4-tetrahydro-2-isoquinolinyl)ethyl]phenyl}-4,5-dimethoxy-2-(3-quinolylcarboxamido)benzamide
   Show/Hide
C38H38N4O6
 2
1
IC50 = 680 nM
   TI
   LI
   LO
   TS
2
IC50 = 1500 nM
   TI
   LI
   LO
   TS
CP0049981
3',5-dihydroxy-3,4',7-trimethoxyflavone
   Show/Hide
C18H16O7
 1
1
IC50 = 680 nM
   TI
   LI
   LO
   TS
CP0269713
N-[4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]-2-[(4-nitrobenzoyl)amino]benzamide
   Show/Hide
C33H32N4O6
 1
1
IC50 = 690 nM
   TI
   LI
   LO
   TS
CP0427782
(E)-3-(3,4-dimethoxyphenyl)-1-(2-hydroxy-4,6-dimethoxyphenyl)prop-2-en-1-one
   Show/Hide
C19H20O6
 1
1
IC50 = 750 nM
   TI
   LI
   LO
   TS
CP0050832
2-(3,4-Dimethoxy-phenyl)-5-hydroxy-3,7-dimethoxy-chromen-4-one
   Show/Hide
C19H18O7
 1
1
IC50 = 900 nM
   TI
   LI
   LO
   TS
CP0136582
N-[2-[[4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]carbamoyl]phenyl]-3,4-dimethoxybenzamide
   Show/Hide
C35H37N3O6
 1
1
IC50 = 930 nM
   TI
   LI
   LO
   TS
CP0161706
(E)-1-(2,4-dihydroxyphenyl)-3-(3,4-dimethoxyphenyl)prop-2-en-1-one
   Show/Hide
C17H16O5
 1
1
IC50 = 930 nM
   TI
   LI
   LO
   TS
CP0446664
2-[(4-nitrobenzoyl)amino]-N-(4-propylphenyl)benzamide
   Show/Hide
C23H21N3O4
 1
1
IC50 = 940 nM
   TI
   LI
   LO
   TS
CP0036082
N-(3-chloro-4-fluorophenyl)-7-methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4-amine
   Show/Hide
C22H24ClFN4O3
 1
1
IC50 = 1100 nM
   TI
   LI
   LO
   TS
CP0429462
2-(3,4-Dimethoxy-phenyl)-3,5,6,7,8-pentamethoxy-chromen-4-one
   Show/Hide
C22H24O9
 1
1
IC50 = 1600 nM
   TI
   LI
   LO
   TS
CP0441268
(E)-3-(3,4-dimethoxyphenyl)-1-(2-hydroxynaphthalen-1-yl)prop-2-en-1-one
   Show/Hide
C21H18O4
 1
1
IC50 = 1840 nM
   TI
   LI
   LO
   TS
CP0418765
(E)-1-(2-hydroxynaphthalen-1-yl)-3-(3-methoxyphenyl)prop-2-en-1-one
   Show/Hide
C20H16O3
 1
1
IC50 = 1930 nM
   TI
   LI
   LO
   TS
CP0123903
5,4'-dihydroxy-3,6,7-trimethoxyflavanone
   Show/Hide
C18H16O7
 1
1
IC50 = 2000 nM
   TI
   LI
   LO
   TS
CP0147681
(E)-3-(3,4-dimethoxyphenyl)-1-(2-hydroxy-4-methoxyphenyl)prop-2-en-1-one
   Show/Hide
C18H18O5
 1
1
IC50 = 2170 nM
   TI
   LI
   LO
   TS
CP0480465
(E)-1-(3',4'-Dimethoxyphenyl)-3-(4''-methoxyphenyl)prop-2-en-1-one
   Show/Hide
C18H18O4
 1
1
IC50 = 2190 nM
   TI
   LI
   LO
   TS
CP0441261
(E)-1-(2,4-dimethoxyphenyl)-3-(3,4-dimethoxyphenyl)prop-2-en-1-one
   Show/Hide
C19H20O5
 1
1
IC50 = 2200 nM
   TI
   LI
   LO
   TS
CP0342156
(E)-1-(2',4'-Dimethoxyphenyl)-3-(4''-methoxyphenyl)prop-2-en-1-one
   Show/Hide
C18H18O4
 1
1
IC50 = 2340 nM
   TI
   LI
   LO
   TS
CP0441263
(E)-3-(3,4-dimethoxyphenyl)-1-(1-hydroxynaphthalen-2-yl)prop-2-en-1-one
   Show/Hide
C21H18O4
 1
1
IC50 = 2500 nM
   TI
   LI
   LO
   TS
CP0015787
5,7-dihydroxy-2-phenyl-4H-chromen-4-one
   Show/Hide
C15H10O4
 1
1
IC50 = 2600 nM
   TI
   LI
   LO
   TS
CP0395784
(E)-3-(4-chlorophenyl)-1-(3,4-dimethoxyphenyl)prop-2-en-1-one
   Show/Hide
C17H15ClO3
 1
1
IC50 = 2720 nM
   TI
   LI
   LO
   TS
CP0428495
(E)-1-(2-hydroxynaphthalen-1-yl)-3-phenylprop-2-en-1-one
   Show/Hide
C19H14O2
 1
1
IC50 = 2770 nM
   TI
   LI
   LO
   TS
CP0073756
5-Hydroxy-6-methyl-7-methoxy-flavone
   Show/Hide
C17H14O4
 1
1
IC50 = 2800 nM
   TI
   LI
   LO
   TS
CP0389298
(E)-1-(2,4-dihydroxyphenyl)-3-(3-methoxyphenyl)prop-2-en-1-one
   Show/Hide
C16H14O4
 1
1
IC50 = 2800 nM
   TI
   LI
   LO
   TS
CP0385411
(E)-3-(4-chlorophenyl)-1-(2,4-dimethoxyphenyl)prop-2-en-1-one
   Show/Hide
C17H15ClO3
 1
1
IC50 = 3090 nM
   TI
   LI
   LO
   TS
CP0418784
(E)-3-(2-chlorophenyl)-1-(2,4-dimethoxyphenyl)prop-2-en-1-one
   Show/Hide
C17H15ClO3
 1
1
IC50 = 3130 nM
   TI
   LI
   LO
   TS
CP0201213
(E)-1-(2-hydroxy-4-methoxyphenyl)-3-(3-methoxyphenyl)prop-2-en-1-one
   Show/Hide
C17H16O4
 1
1
IC50 = 3150 nM
   TI
   LI
   LO
   TS
CP0418786
(E)-1-(2,4-dihydroxyphenyl)-3-(2-chlorophenyl)-2-propen-1-one (6)
   Show/Hide
C15H11ClO3
 1
1
IC50 = 3210 nM
   TI
   LI
   LO
   TS
CP0197181
(E)-1,3-bis(3,4-dimethoxyphenyl)prop-2-en-1-one
   Show/Hide
C19H20O5
 1
1
IC50 = 3280 nM
   TI
   LI
   LO
   TS
CP0387978
(E)-1-(2-hydroxynaphthalen-1-yl)-3-(4-methoxyphenyl)prop-2-en-1-one
   Show/Hide
C20H16O3
 1
1
IC50 = 3810 nM
   TI
   LI
   LO
   TS
CP0475086
1-(4-(2-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)phenyl)-3-(4-nitrophenyl)urea
   Show/Hide
C26H28N4O5
 1
1
IC50 = 3890 nM
   TI
   LI
   LO
   TS
CP0002778
4-[(4-methylpiperazin-1-yl)methyl]-N-[4-methyl-3-[(4-pyridin-3-ylpyrimidin-2-yl)amino]phenyl]benzamide
   Show/Hide
C29H31N7O
 1
1
IC50 = 4070 nM
   TI
   LI
   LO
   TS
CP0043433
1-(2-hydroxy-4-methoxyphenyl)-3-(4-methoxyphenyl)prop-2-en-1-one
   Show/Hide
C17H16O4
 1
1
IC50 = 4200 nM
   TI
   LI
   LO
   TS
CP0201969
2-(3,4-Dimethoxy-phenyl)-5,6,7,8-tetramethoxy-chromen-4-one
   Show/Hide
C21H22O8
 1
1
IC50 = 4400 nM
   TI
   LI
   LO
   TS
CP0418783
Chalcone, 9
   Show/Hide
C17H16O4
 1
1
IC50 = 5070 nM
   TI
   LI
   LO
   TS
CP0428640
(E)-3-(2-chlorophenyl)-1-(2-hydroxynaphthalen-1-yl)prop-2-en-1-one
   Show/Hide
C19H13ClO2
 1
1
IC50 = 5210 nM
   TI
   LI
   LO
   TS
CP0389850
(E)-3-(2-chlorophenyl)-1-(2-hydroxy-4,6-dimethoxyphenyl)prop-2-en-1-one
   Show/Hide
C17H15ClO4
 1
1
IC50 = 5270 nM
   TI
   LI
   LO
   TS
CP0202456
FLAVOKAWAIN A
   Show/Hide
C18H18O5
 1
1
IC50 = 5830 nM
   TI
   LI
   LO
   TS
CP0013882
5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one
   Show/Hide
C15H10O5
 1
1
IC50 = 5900 nM
   TI
   LI
   LO
   TS
CP0067438
substituted chalcone, 5m
   Show/Hide
C15H11ClO3
 1
1
IC50 = 6070 nM
   TI
   LI
   LO
   TS
CP0503982
2-(3,3-Diethylthioureido)benzo[b]thiophene-3-carboxylic Acid
   Show/Hide
C14H16N2O2S2
 1
1
IC50 = 6160 nM
   TI
   LI
   LO
   TS
CP0030681
3,5,7-trihydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one
   Show/Hide
C15H10O6
 1
1
IC50 = 6200 nM
   TI
   LI
   LO
   TS
CP0437734
1-(4-(2-(3,4-dihydroisoquinolin-2(1H)-yl)ethyl)phenyl)-3-(2-nitrophenyl)urea
   Show/Hide
C24H24N4O3
 1
1
IC50 = 6760 nM
   TI
   LI
   LO
   TS
CP0441258
(E)-3-(2-chlorophenyl)-1-(2-hydroxy-4-methoxyphenyl)prop-2-en-1-one
   Show/Hide
C16H13ClO3
 1
1
IC50 = 6850 nM
   TI
   LI
   LO
   TS
CP0371729
N-[4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]-4-nitrobenzamide
   Show/Hide
C26H27N3O5
 1
1
IC50 = 6920 nM
   TI
   LI
   LO
   TS
CP0020849
2-(3,4-dihydroxyphenyl)-3,5,7-trihydroxy-4H-chromen-4-one
   Show/Hide
C15H10O7
 1
1
IC50 = 7600 nM
   TI
   LI
   LO
   TS
CP0381037
5,7-dimethoxy-6-methyl-2-phenylchromen-4-one
   Show/Hide
C18H16O4
 1
1
IC50 = 8000 nM
   TI
   LI
   LO
   TS
CP0335075
2-(3,4-dimethoxyphenyl)-5,6,7-trimethoxy-4H-chromen-4-one
   Show/Hide
C20H20O7
 1
1
IC50 = 8300 nM
   TI
   LI
   LO
   TS
CP0387997
(E)-3-(3,4-dichlorophenyl)-1-(2-hydroxynaphthalen-1-yl)prop-2-en-1-one
   Show/Hide
C19H12Cl2O2
 1
1
IC50 = 8780 nM
   TI
   LI
   LO
   TS
CP0012708
5,7-dihydroxy-3-(4-hydroxyphenyl)-4H-chromen-4-one
   Show/Hide
C15H10O5
 1
1
IC50 = 8800 nM
   TI
   LI
   LO
   TS
CP0503975
(R,S)-2-(3,3-Diethylthioureido)-4-methyl-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylic Acid
   Show/Hide
C15H22N2O2S2
 1
1
IC50 = 9100 nM
   TI
   LI
   LO
   TS
CP0271942
6-Methoxy-2-phenyl-chromen-4-one
   Show/Hide
C16H12O3
 1
1
IC50 = 10000 nM
   TI
   LI
   LO
   TS
CP0426903
N-[2-[[4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]carbamoylamino]phenyl]-3,4-dimethoxybenzamide
   Show/Hide
C35H38N4O6
 1
1
IC50 = 10200 nM
   TI
   LI
   LO
   TS
CP0505758
1-(4-(2-(6,7-Dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)phenyl)-3-(2-nitrophenyl)urea
   Show/Hide
C26H28N4O5
 1
1
IC50 = 10200 nM
   TI
   LI
   LO
   TS
CP0407649
2-(3-Cyclohexyl-3-methylthioureido)thiophene-3-carboxylic Acid
   Show/Hide
C13H18N2O2S2
 1
1
IC50 = 10200 nM
   TI
   LI
   LO
   TS
CP0409882
5,7-Dimethoxy-2-phenyl-chromen-4-one
   Show/Hide
C17H14O4
 1
1
IC50 = 11000 nM
   TI
   LI
   LO
   TS
CP0441265
(E)-3-(2-chlorophenyl)-1-(3,4-dimethoxyphenyl)prop-2-en-1-one
   Show/Hide
C17H15ClO3
 1
1
IC50 = 11040 nM
   TI
   LI
   LO
   TS
CP0395785
(E)-1-(1-hydroxynaphthalen-2-yl)-3-(3-methoxyphenyl)prop-2-en-1-one
   Show/Hide
C20H16O3
 1
1
IC50 = 11890 nM
   TI
   LI
   LO
   TS
CP0469230
5-hydroxy-7-methoxy-6-methyl-2-phenyl-2,3-dihydrochromen-4-one
   Show/Hide
C17H16O4
 1
1
IC50 = 12000 nM
   TI
   LI
   LO
   TS
CP0095207
substituted chalcone, 5i
   Show/Hide
C16H13ClO3
 1
1
IC50 = 13510 nM
   TI
   LI
   LO
   TS
CP0477860
(1R,5S,7R,13R,20R)-5-hydroxy-10,11,13,14,15-pentamethoxy-7,20-diphenyl-2,8,21-trioxapentacyclo[11.8.0.01,17.03,12.04,9]henicosa-3,9,11,14,17-pentaen-16-one
   Show/Hide
C35H34O10
 1
1
IC50 = 15000 nM
   TI
   LI
   LO
   TS
CP0418785
(E)-1-(1-hydroxynaphthalen-2-yl)-3-(4-methoxyphenyl)prop-2-en-1-one
   Show/Hide
C20H16O3
 1
1
IC50 = 16920 nM
   TI
   LI
   LO
   TS
CP0042041
4',5,6,7,8-pentamethoxyflavone
   Show/Hide
C20H20O7
 1
1
IC50 = 17000 nM
   TI
   LI
   LO
   TS
CP0847896
Dimethylcryptostrobin
   Show/Hide
C18H18O4
 1
1
IC50 = 17000 nM
   TI
   LI
   LO
   TS
CP0439114
2-Amino-N-{4-[2-(3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl}benzamide
   Show/Hide
C24H25N3O
 1
1
IC50 = 17800 nM
   TI
   LI
   LO
   TS
CP0003356
(E)-1-(1-hydroxynaphthalen-2-yl)-3-phenylprop-2-en-1-one
   Show/Hide
C19H14O2
 1
1
IC50 = 24320 nM
   TI
   LI
   LO
   TS
CP0081624
2-phenylchromen-4-one
   Show/Hide
C15H10O2
 1
1
IC50 = 26000 nM
   TI
   LI
   LO
   TS
CP0508351
5,7-dihydroxy-6-methyl-2-phenyl-2,3-dihydrochromen-4-one
   Show/Hide
C16H14O4
 1
1
IC50 = 26000 nM
   TI
   LI
   LO
   TS
CP0441259
(E)-3-(3,4-dichlorophenyl)-1-(1-hydroxynaphthalen-2-yl)prop-2-en-1-one
   Show/Hide
C19H12Cl2O2
 1
1
IC50 = 26120 nM
   TI
   LI
   LO
   TS
CP0186353
(+/-)-5-hydroxy-7-methoxyflavanone
   Show/Hide
C16H14O4
 1
1
IC50 = 31000 nM
   TI
   LI
   LO
   TS
CP0031166
(E)-1-(2-Hydroxy-4-methoxy-phenyl)-3-phenyl-propenone
   Show/Hide
C16H14O3
 1
1
IC50 = 31020 nM
   TI
   LI
   LO
   TS
CP0321555
5,7-Dimethoxy-2-phenyl-chroman-4-one
   Show/Hide
C17H16O4
 1
1
IC50 = 32000 nM
   TI
   LI
   LO
   TS
CP0422163
2-Amino-N-{4-[2-(6,7-dimethoxy-3,4-dihydro-1Hisoquinolin-2-yl)ethyl]phenyl}benzamide
   Show/Hide
C26H29N3O3
 1
1
IC50 = 32400 nM
   TI
   LI
   LO
   TS
CP0047641
1-(2,4-Dihydroxy-phenyl)-3-(4-methoxy-phenyl)-propenone
   Show/Hide
C16H14O4
 1
1
IC50 = 33320 nM
   TI
   LI
   LO
   TS
CP0381036
(2R,5S,7R,10S,11R,15R,17S)-15-hydroxy-2,7,10,11,20,21-hexamethoxy-5,17-diphenyl-4,12,18-trioxapentacyclo[11.8.0.02,11.03,8.014,19]henicosa-1(21),3(8),13,19-tetraen-9-one
   Show/Hide
C36H38O11
 1
1
IC50 = 40000 nM
   TI
   LI
   LO
   TS
CP0478121
6-Methoxyflavanone
   Show/Hide
C16H14O3
 1
1
IC50 = 46000 nM
   TI
   LI
   LO
   TS
CP0438329
(1R,5S,7R,13R,20R)-5,10,11,13,14,15-hexamethoxy-7,20-diphenyl-2,8,21-trioxapentacyclo[11.8.0.01,17.03,12.04,9]henicosa-3,9,11,14,17-pentaen-16-one
   Show/Hide
C36H36O10
 1
1
IC50 = 47000 nM
   TI
   LI
   LO
   TS
CP0040161
2-(2,4-dihydroxyphenyl)-3,5,7-trihydroxy-1-benzopyran-4-one
   Show/Hide
C15H10O7
 1
1
IC50 = 49000 nM
   TI
   LI
   LO
   TS
CP0422353
N-[4-[2-(3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]-2-nitrobenzamide
   Show/Hide
C24H23N3O3
 1
1
IC50 = 51300 nM
   TI
   LI
   LO
   TS
CP0497298
1-(2-Aminophenyl)-3-(4-(2-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)-phenyl)urea
   Show/Hide
C26H30N4O3
 1
1
IC50 = 66100 nM
   TI
   LI
   LO
   TS
CP0422162
1-(4-Aminophenyl)-3-(4-(2-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)ethyl)-phenyl)urea
   Show/Hide
C26H30N4O3
 1
1
IC50 = 74100 nM
   TI
   LI
   LO
   TS
CP0439113
N-[4-[2-(6,7-dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)ethyl]phenyl]-2-nitrobenzamide
   Show/Hide
C26H27N3O5
 1
1
IC50 = 77600 nM
   TI
   LI
   LO
   TS
CP0016936
(3R,4S,5R,6R)-5-hydroxy-6-[(2-hydroxy-3-{[4-hydroxy-3-(3-methylbut-2-en-1-yl)benzene]amido}-8-methyl-4-oxo-4H-chromen-7-yl)oxy]-3-methoxy-2,2-dimethyloxan-4-yl carbamate
   Show/Hide
C31H36N2O11
 1
1
IC50 = 85100 nM
   TI
   LI
   LO
   TS
Protein family and CMB statistics Related to the Cell Line
Cell Lines Derived from the same Tissue Source (Pleural effusion)
Cell Line Name Organism Disease
U-937 Homo sapiens (Human) Adult acute monocytic leukemia
SU-DHL-1 Homo sapiens (Human) Anaplastic large cell lymphoma, ALK-positive
SR Homo sapiens (Human) Anaplastic large cell lymphoma, ALK-positive
MC116 Homo sapiens (Human) B-cell non-Hodgkin lymphoma
K-562 Homo sapiens (Human) Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
K562/A02 Homo sapiens (Human) Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
K562/Adr Homo sapiens (Human) Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
K562/R7 Homo sapiens (Human) Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
K562/DOX Homo sapiens (Human) Blast phase chronic myelogenous leukemia, BCR-ABL1 positive
MDA-MB-231 Homo sapiens (Human) Breast adenocarcinoma
MDA-MB-415 Homo sapiens (Human) Breast adenocarcinoma
MDA-MB-468 Homo sapiens (Human) Breast adenocarcinoma
SK-BR-3 Homo sapiens (Human) Breast adenocarcinoma
AU565 Homo sapiens (Human) Breast adenocarcinoma
CAL-51 Homo sapiens (Human) Breast carcinoma
CAL-120 Homo sapiens (Human) Breast carcinoma
DG-75 Homo sapiens (Human) Burkitt lymphoma
SUP-T1 Homo sapiens (Human) Childhood T lymphoblastic lymphoma
Pfeiffer Homo sapiens (Human) Diffuse large B-cell lymphoma germinal center B-cell type
WSU-DLCL2 Homo sapiens (Human) Diffuse large B-cell lymphoma germinal center B-cell type
Karpas-422 Homo sapiens (Human) Diffuse large B-cell lymphoma germinal center B-cell type
DoHH2 Homo sapiens (Human) Diffuse large B-cell lymphoma germinal center B-cell type
KATO III Homo sapiens (Human) Down syndrome
GIST-T1 Homo sapiens (Human) Gastrointestinal stromal tumor
GIST-5R Homo sapiens (Human) Gastrointestinal stromal tumor
MZ-CRC-1 Homo sapiens (Human) Hereditary thyroid gland medullary carcinoma
L-428 Homo sapiens (Human) Hodgkin lymphoma
KM-H2 Homo sapiens (Human) Hodgkin lymphoma
T-47D Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7/2a Homo sapiens (Human) Invasive breast carcinoma of no special type
T-47 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7 MX100 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7/VP Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7-2a Homo sapiens (Human) Invasive breast carcinoma of no special type
T47D:A18 Homo sapiens (Human) Invasive breast carcinoma of no special type
MVLN Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7/Topo Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7/NOD2 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7aro Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7/MRP1-M6 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7/MRP1-10 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7/MRP1-M24 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7/NOD1 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7piGST Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7-Y1 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7/ADM Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7:WS8 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7-FLV1000 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7-neo/Her2 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7 cl.24 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF-7/DX1 Homo sapiens (Human) Invasive breast carcinoma of no special type
MCF7-LC3 Homo sapiens (Human) Invasive breast carcinoma of no special type
T47D-KBluc Homo sapiens (Human) Invasive breast carcinoma of no special type
Calu-6 Homo sapiens (Human) Lung adenocarcinoma
Calu-3 Homo sapiens (Human) Lung adenocarcinoma
HCC78 Homo sapiens (Human) Lung adenocarcinoma
NCI-H3122 Homo sapiens (Human) Lung adenocarcinoma
NCI-H3255 Homo sapiens (Human) Lung adenocarcinoma
NCI-H2122 Homo sapiens (Human) Lung adenocarcinoma
COR-L105 Homo sapiens (Human) Lung adenocarcinoma
NCI-H1437 Homo sapiens (Human) Lung adenocarcinoma
HCC4006 Homo sapiens (Human) Lung adenocarcinoma
NCI-H1792 Homo sapiens (Human) Lung adenocarcinoma
DFCI032 Homo sapiens (Human) Lung adenocarcinoma
NCI-H1355 Homo sapiens (Human) Lung adenocarcinoma
NCI-H460 Homo sapiens (Human) Lung large cell carcinoma
U-1810 Homo sapiens (Human) Lung large cell carcinoma
COR-L23/R Homo sapiens (Human) Lung large cell carcinoma
H460/MX20 Homo sapiens (Human) Lung large cell carcinoma
H460R Homo sapiens (Human) Lung large cell carcinoma
H69AR Homo sapiens (Human) Lung small cell carcinoma
NCI-H69 Homo sapiens (Human) Lung small cell carcinoma
GLC-4/ADR Homo sapiens (Human) Lung small cell carcinoma
STC 1 Homo sapiens (Human) Lung small cell carcinoma
RERF-LC-A1 Homo sapiens (Human) Lung squamous cell carcinoma
Calu-1 Homo sapiens (Human) Lung squamous cell carcinoma
HCC95 Homo sapiens (Human) Lung squamous cell carcinoma
RERF-LC-AI Tet-off Homo sapiens (Human) Lung squamous cell carcinoma
NCI-H1650 Homo sapiens (Human) Minimally invasive lung adenocarcinoma
NCI-H1666 Homo sapiens (Human) Minimally invasive lung adenocarcinoma
NCI-H929 Homo sapiens (Human) Plasma cell myeloma
KMS-11 Homo sapiens (Human) Plasma cell myeloma
UTMC-2 Homo sapiens (Human) Plasma cell myeloma
KMS-12-PE Homo sapiens (Human) Plasma cell myeloma
NCI-H226 Homo sapiens (Human) Pleural epithelioid mesothelioma
Karpas-1106P Homo sapiens (Human) Primary mediastinal (thymic) large B-cell lymphoma